The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cole Hugh M since 2016.
This trader's CIK number is 1604646.
At the time of last reporting, Cole Hugh M was the Chief Operating Officer of Jounce Therapeutics, Inc.. (stock ticker symbol JNCE).
Also see all insider trading activities at Jounce Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | ARIA | 0 | $0 | 6,012 | $42,384 | 26,666 | $46,575 |
| 2015 | ARIA | 0 | $0 | 0 | $0 | 19,167 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | JNCE | 0 | $0 | 16,634 | $18,480 | 0 | $0 |
| 2022 | JNCE | 0 | $0 | 9,673 | $66,579 | 0 | $0 |
| 2021 | JNCE | 0 | $0 | 24,219 | $257,942 | 10,000 | $54,750 |
| 2020 | JNCE | 0 | $0 | 4,806 | $30,689 | 0 | $0 |
| 2019 | JNCE | 0 | $0 | 2,336 | $9,328 | 0 | $0 |
| 2018 | JNCE | 1,900 | $14,896 | 0 | $0 | 0 | $0 |
1. Ariad Pharmaceuticals Inc (ARIA)
2. Jounce Therapeutics, Inc. (JNCE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-25 | ARIA | Option Ex | 19,167 | .00 | 0 |
| 2016-06-27 | ARIA | Option Ex | 19,166 | .00 | 0 |
| 2016-06-28 | ARIA | Sale | 6,012 | 7.05 | 42,384 |
| 2016-03-16 | ARIA | Option Ex | 7,500 | 6.21 | 46,575 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-09 | JNCE | Sale | 7,452 | 1.10 | 8,197 |
| 2023-01-10 | JNCE | Sale | 9,182 | 1.12 | 10,283 |
| 2022-01-10 | JNCE | Sale | 6,205 | 6.65 | 41,263 |
| 2022-01-07 | JNCE | Sale | 3,468 | 7.30 | 25,316 |
| 2021-01-22 | JNCE | Sale | 18,000 | 11.95 | 215,100 |
| 2021-01-22 | JNCE | Option Ex | 10,000 | 5.47 | 54,750 |
| 2021-01-07 | JNCE | Sale | 2,879 | 6.76 | 19,462 |
| 2021-01-08 | JNCE | Sale | 3,340 | 7.00 | 23,380 |
| 2020-08-17 | JNCE | Sale | 454 | 4.86 | 2,206 |
| 2020-08-18 | JNCE | Sale | 744 | 4.71 | 3,504 |
| 2020-08-14 | JNCE | Sale | 984 | 4.64 | 4,565 |
| 2020-01-07 | JNCE | Sale | 2,624 | 7.78 | 20,414 |
| 2019-08-14 | JNCE | Sale | 670 | 4.10 | 2,746 |
| 2019-08-15 | JNCE | Sale | 648 | 4.00 | 2,592 |
| 2019-08-16 | JNCE | Sale | 1,018 | 3.92 | 3,990 |
| 2018-06-15 | JNCE | Buy | 1,900 | 7.84 | 14,896 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cole Hugh M (Chief Operating Officer of Jounce Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.